The Future of Vitamin D: Extraskeletal Effects

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This review highlights current Russian and international scientific data on the role of vitamin D in a wide range of physiological processes, with a special emphasis on its extraskeletal functions, clinical implications, and manifestations. A search and analysis of the medical scientific data from 2004 to 2023 was undertaken using the databases eLibrary.RU, the Russian National Library, and the Fundamental Library of the S.M. Kirov Military Medical Academy, and the international search platforms PubMed and Medscape. Key scientific publications were reviewed, including outcomes from preclinical studies on laboratory animals utilizing vitamin D supplements and clinical studies involving patients with vitamin D deficiency. It examines vitamin D metabolism and its involvement in the immune function, as well as in the cardiovascular, respiratory, digestive, endocrine, nervous, reproductive, and other systems. Vitamin D deficiency is clearly reflected in the development, pathogenesis, and progression of diverse prevalent human diseases, including infectious, chronic inflammatory, allergic, systemic autoimmune, and various neoplastic conditions. The article highlights key historical milestones in the discovery of vitamin D and its metabolites, their health impacts, and the role of vitamin D deficiency in disease development. Preclinical and clinical studies have largely validated the effects of vitamin D at the cellular, tissue, and organ levels, including its role in regulating the function of various physiological systems as well as cellular proliferation and differentiation. Numerous long-term prospective studies are ongoing, linking low vitamin D levels to a wide spectrum of human diseases. This continues to generate considerable scientific interest and enthusiasm for exploring the effects of dietary vitamin D supplementation on human health, despite inconsistent results from clinical studies.

Full Text

Restricted Access

About the authors

Alexey N. Kuchmin

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0009-0009-7074-8747
SPIN-code: 7787-1364

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

Olga V. Diskalenko

Kirov Military Medical Academy

Author for correspondence.
Email: vmeda-nio@mil.ru
ORCID iD: 0000-0001-9927-7779
SPIN-code: 5685-6375

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

Anna B. Izotova

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0001-8356-1863
SPIN-code: 8985-7950

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

Vitaly V. Ekimov

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0003-3750-4301
SPIN-code: 2901-9561
Russian Federation, Saint Petersburg

References

  1. Šarac I, Djekić-Ivanković M, Debeljak-Martačić J. Editorial: The role of vitamin D in metabolic and cardiovascular health. Front Nutr. 2023;10:1193758. doi: 10.3389/fnut.2023.1193758
  2. Januarlo Silva IC, Lazaretti-Castro M. Vitamin D metabolism and extraskeletal outcomes: an update. Arch Endocrinol Metab. 2022;66(5): 748–755. doi: 10.20945/2359-3997000000565
  3. Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014;348:g1903. doi: 10.1136/bmj.g1903
  4. Renke G, Starling-Soares B, Baesso T, et al. Effects of vitamin D on cardiovascular risk and oxidative stress. Nutrients. 2023;15(3):769–786. doi: 10.3390/nu15030769
  5. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080–1086. doi: 10.1093/ajcn/87.4.1080S
  6. Ebeling PR, Adler RA, Jones G, et al. Management of endocrine disease: therapeutics of vitamin D. Eur J Endocrinol. 2018;179(5):239–259. doi: 10.1530/EJE-18-0151
  7. Pigarova EA, Rozhinskaya LYa, Belaya JE, et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016;62(4): 60–84. doi: 10.14341/probl201662460-84 EDN: WMZICF
  8. Kryukov EV, Lesnyak OM, Aganov DS, et al. Vitamin D sufficiency and its relationship with indicators of physical development and the state of bone tissue in cadets of a military higher educational institution. Annals of the Russian academy of medical sciences. 2024;79(3):271–280. doi: 10.15690/vramn14857 EDN: MEGZCB
  9. Leal ACGB, Corrêa MP, Holick MF, et al. Sun-induced production of vitamin D3 throughout 1 year in tropical and subtropical regions: relationship with latitude, cloudiness, UV-B exposure and solar zenith angle. Photochem Photobiol Sci. 2021;20(2):265–274. doi: 10.1007/s43630-021-00015-z
  10. Levin GP, Robinson-Cohen C, de Boer IH, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA. 2012;308(18):1898–1905. doi: 10.1001/jama.2012.17304
  11. Jones G. 100 years of vitamin D: Historical aspects of vitamin D. Endocr Connect. 2022;11(4):e210594. doi: 10.1530/EC-21-0594
  12. Kulikov VA, Grebennikov IN.The role of vitamin D in the development of vascular calcification and atherosclerosis. Bulletin of the Vitebsk State Medical University. 2012;11(4):5–14. EDN: PRYXTL (In Russ.)
  13. Haussler MR, Livingston S, Sabir ZL, et al. Vitamin D receptor mediates a myriad of biological actions dependent on its 1,25-Dihydroxyvitamin D ligand: Distinct regulatory themes revealed by induction of klotho and fibroblast growth Factor-23. JBMR Plus. 2020;5(1):e10432. doi: 10.1002/jbm4.10432
  14. Durgarao Y, Manjrekar PA, Adhikari P, et al. comprehensive review on diabetes associated cardiovascular complications – the vitamin D perspective. Cardiovasc Hematol Disord Drug Targets. 2019;19(2):139–153. doi: 10.2174/1871529X19666190114155302
  15. Lupton JR, Faridi KF, Martin SS, et al. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The very large database of lipids (VLDL-3) study. J Clin Lipidol. 2016;10(1):72–81.E1. doi: 10.1016/j.jacl.2015.09.006
  16. Warren T, McAllister R, Morgan A, et al. the interdependency and co-regulation of the vitamin D and cholesterol metabolism. Cells. 2021;10(8):2007. doi: 10.3390/cells10082007
  17. Schmitt EB, Nahas-Neto J, Bueloni-Dias F, et al. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women. Maturitas. 2018;107:97–102. doi: 10.1016/j.maturitas.2017.10.011
  18. Thompson B, Waterhouse M, English DR, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023;381:e075230. doi: 10.1136/bmj-2023-075230
  19. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44. doi: 10.1056/NEJMoa1809944
  20. Scragg R, Stewart AW, Waayer D, et al. Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: A randomized clinical trial. JAMA Cardiol. 2017;2(6): 608–616. doi: 10.1001/jamacardio.2017.0175
  21. Chen X, Zhou M, Yan H, et al. Association of serum total 25-hydroxy-vitamin D concentration and risk of all-cause, cardiovascular and malignancies-specific mortality in patients with hyperlipidemia in the United States. Front Nutrit. 2022;9:971720. doi: 10.3389/fnut.2022.971720
  22. Bouillon R, Manousaki D, Rosen C, et al. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol. 2022;18(2):96–110. doi: 10.1038/s41574-021-00593-z
  23. Moslemi E, Musazadeh V, Kavyani Z, et al. Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis. Pharmacol Res. 2022;186:106484. doi: 10.1016/j.phrs.2022.106484
  24. Elmoselhi AB, Seif Allah M, Bouzid A, et al. Circulating microRNAs as potential biomarkers of early vascular damage in vitamin D deficiency, obese, and diabetic patients. PLoS One. 2023;18(3): 0283608. doi: 10.1371/journal.pone.0283608
  25. Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89-90:387–392. doi: 10.1016/j.jsbmb.2004.03.004
  26. Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al. Effect of vitamin D supplementation, Omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: The DO-HEALTH randomized clinical trial. JAMA. 2020;324(18):1855–1868. doi: 10.1001/jama.2020.16909
  27. Vijay G, Xu Z, Nida S, Vin T. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr. 2011;94(1):225–233. doi: 10.3945/ajcn.111.013516
  28. Petersen RA, Dalskov S-M, Sørensen LB, et al. Vitamin D status is associated with cardiometabolic markers in 8-11-year-old children, independently of body fat and physical activity. Br J Nutr. 2015;114(10): 1647–1655. doi: 10.1017/S0007114515003372
  29. Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28(3):205–221. doi: 10.1007/s10654-013-9790-2
  30. Snijder MB, Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007;261(6):558–565. doi: 10.1111/j.1365-2796.2007.01778.x
  31. Reis JP, von Mühlen D, Kritz-Silverstein D, et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30(6):1549–1555. doi: 10.2337/dc06-2438
  32. Sluyter JD, Camargo CA Jr, Stewart AW, et al. Effect of monthly, high-dose, long-term vitamin D supplementation on central blood pressure parameters: a randomized controlled trial substudy. J Am Heart Assoc. 2017;6(10):e006802. doi: 10.1161/JAHA.117.00680244
  33. Van Ballegooijen AJ, Kestenbaum B, Sachs MC, et al. Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2014;63(12):1214–1222. doi: 10.1016/j.jacc.2014.01.012
  34. Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10(2):1001383. doi: 10.1371/journal.pmed.1001383
  35. Bernardo DRD, Canale D, Nascimento MM, et al. The association between obesity and vitamin D deficiency modifies the progression of kidney disease after ischemia/reperfusion injury. Front Nutr. 2022;9(95):952028. doi: 10.3389/fnut.2022.952028
  36. Pereira-Santos M, Costa PR, Assis AM, et al. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obesity rev. 2015;16(4):341–349. doi: 10.1111/obr.12239
  37. Unger MD, Cuppari L, Titan SM, et al. Vitamin D status in a sunny country: where has the sun gone? Clin Nutr. 2010;29(6):784–788. doi: 10.1016/j.clnu.2010.06.009
  38. Karampela I, Sakelliou A, Vallianou N, et al. Vitamin D and obesity: Current evidence and controversies. Curr Obes Rep. 2021;10(2):162–180. doi: 10.1007/s13679-021-00433-1
  39. Miricescu D, Balan DG, Tulin A, et al. Impact of adipose tissue in chronic kidney disease development (Review). Exp Ther Med. 2021;21(5):539. doi: 10.3892/etm.2021.9969
  40. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132(6):2169–2180. doi: 10.1053/j.gastro.2007.03.059
  41. Cojic M, Kocic R, Klisic A, Kocic G. The effects of vitamin D supplementation on metabolic and oxidative stress markers in patients with type 2 diabetes: A 6-month follow up randomized controlled study. Front Endocrinol. 2021;12:610893. doi: 10.3389/fendo.2021.610893
  42. Stepanova A.P., Karonova T.L. The place of vitamin D supplementation in the complex therapy of type 2 diabetic patients with diabetic peripheral neuropathy. Consilium Medicum. 2019;21(12):59–66. doi: 10.26442/20751753.2019.12.190677 EDN: DRQVJZ
  43. Argano C, Mirarchi L, Amodeo S, et al. The role of vitamin D and its molecular bases in insulin resistance, diabetes, metabolic syndrome, and cardiovascular disease: State of the art. Int J Mol Sci. 2023;24(20):15485. doi: 10.3390/ijms242015485
  44. Dawson-Hughes B, Staten MA, Knowler WC, et al. Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: A secondary analysis from the vitamin D and type 2 diabetes (D2d) study. Diabetes Care. 2020;43(12):2916–2922. doi: 10.2337/dc20-1765
  45. Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin d: current evidence and outstanding questions. Endocr Rev. 2019;40(4):1109–1151. doi: 10.1210/er.2018-00126
  46. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832–2838. doi: 10.1001/jama.296.23.2832
  47. Roth DE, Leung M, Mesfin E, et al. Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials. BMJ. 2017;359:5237. doi: 10.1136/bmj.j5237
  48. Vargas Buonfiglio LG, Cano M, Pezzulo AA, et al. Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial. BMJ Open Respir Res. 2017;4(1):211. doi: 10.1136/bmjresp-2017-000211
  49. Karonova TL, Vashukova MA, Gusev DA, et al. Vitamin D deficiency as a factor for immunity stimulation and lower risk of acute respiratory infections and COVID-19. Arterial Hypertension. 2020;26(3):295–303. doi: 10.18705/1607-419X-2020-26-3-295-303 EDN: TCRQXL
  50. Camargo CA Jr, Sluyter J, Stewart AW, et al. Effect of monthly high-dose vitamin D supplementation on acute respiratory infections in older adults: a randomized controlled trial. Clin Infect Dis. 2020;71(2):311–317. doi: 10.1093/cid/ciz801
  51. Wang J, Thingholm LB, Skiecevičienė J, et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat Genet. 2016;48(11):1396–1406. doi: 10.1038/ng.3695
  52. Mathyssen C, Gayan-Ramirez G, Bouillon R, Janssens W. Vitamin D supplementation in respiratory diseases: evidence from randomized controlled trials. Pol Arch Intern Med. 2017;127(11):775–784. doi: 10.20452/pamw.4134
  53. Bikle DD. Extraskeletal actions of vitamin D. Ann N Y Acad Sci. 2016;1376(1):29–52. doi: 10.1111/nyas.13219
  54. Tice JA, Halalau A, Burke H. Vitamin D does not prevent cancer or cardiovascular disease: The VITAL trial: Manson JE, Cook NR, Lee IM, et al. (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2020;380(1):33–44. doi: 10.1007/s11606-020-05648-x
  55. Kimball SM, Holick MF. Official recommendations for vitamin D through the life stages in developed countries. Eur J Clin Nutr. 2020;74(11):1514–1518. doi: 10.1038/s41430-020-00706-3
  56. Revez JA, Lin T, Qiao Z, et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun. 2020;11(1):1647. doi: 10.1038/s41467-020-15421-7
  57. Atkinson SA. Recommendations on vitamin D needs in multiple sclerosis from the MS Society of Canada. Public Health Nutr. 2020;23(7):1278–1279. doi: 10.1017/S1368980019005172

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 77762 от 10.02.2020.